Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Plasma CD16+ Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+ Adults on Combination Antiretroviral Therapy. | mBio | 2022 | 35435733 | PubTator, text mining | PubMed |
| Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy. | Front Immunol | 2022 | 35432380 | PubTator, text mining | PubMed |
| BMP2 suppresses the production of pentraxin 3 in human endometrial stromal and decidual stromal cells. | FASEB J | 2022 | 35429060 | PubTator, text mining | PubMed |
| The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome. | Acta Neuropathol Commun | 2022 | 35418158 | PubTator, text mining | PubMed |
| A stepwise data interpretation process for renal amyloidosis typing by LMD-MS. | BMC Nephrol | 2022 | 35418036 | PubTator, text mining | PubMed |
| Cardiac Amyloidosis Treatment. | Methodist Debakey Cardiovasc J | 2022 | 35414852 | PubTator, text mining | PubMed |
| C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2. | Front Cardiovasc Med | 2022 | 35402541 | PubTator, text mining | PubMed |
| Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring. | Transl Psychiatry | 2022 | 35393396 | PubTator, text mining | PubMed |
| Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis. | Front Pharmacol | 2022 | 35387335 | PubTator, text mining | PubMed |
| Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis. | Heart Fail Rev | 2022 | 35386059 | PubTator, text mining | PubMed |
| Proteomic landscape subtype and clinical prognosis of patients with the cognitive impairment by Japanese encephalitis infection. | J Neuroinflammation | 2022 | 35379280 | PubTator, text mining | PubMed |
| Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks. | Front Cell Dev Biol | 2022 | 35372327 | PubTator, text mining | PubMed |
| iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin's Lymphoma. | Front Oncol | 2022 | 35371990 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review. | Front Aging Neurosci | 2022 | 35360215 | PubTator, text mining | PubMed |
| A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. | Arch Toxicol | 2022 | 35357534 | PubTator, text mining | PubMed |
| The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis. | Insights Imaging | 2022 | 35348907 | PubTator, text mining | PubMed |
| Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression. | Int J Oncol | 2022 | 35348189 | PubTator, text mining | PubMed |
| Biomarker Changes in Response to a 12-Week Supplementation of an Oral Nutritional Supplement Enriched with Protein, Vitamin D and HMB in Malnourished Community Dwelling Older Adults with Sarcopenia. | Nutrients | 2022 | 35334853 | PubTator, text mining | PubMed |
| Proteomic Studies of Psoriasis. | Biomedicines | 2022 | 35327421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=23